Demiurge Technologies
Business Services · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Hofstrasse 1a, Zug, Zug, 6300, Switzerla...Phone Number
(540) 366-5199Website
demiurge.technologyRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Demiurge Technologies
Demiurge Technologies specializes in bridging deep learning and life sciences to create virtual patients that can predict clinical trial outcomes for complex diseases. Their platform has achieved high accuracy rates in predicting the efficacy of drugs across various therapeutic areas, including COVID-19, Alzheimer's disease, and immuno-oncology. The company targets pharmaceutical and biotechnology firms looking to enhance drug development processes through innovative predictive modeling. With a proven track record of successful predictions in pivotal clinical trials, Demiurge aims to revolutionize the way clinical efficacy is assessed.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Demiurge Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Demiurge Technologies
Check out if Demiurge Technologies is spiking on competitors!
Product Launch: Get notified when Demiurge Technologies launches new products
Check if Demiurge Technologies has recently received funding, and reach out quickly before it becomes old news!
Demiurge Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Demiurge Technologies had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Demiurge Technologies has new funding data
Earning: See what the market has to say on Demiurge Technologies recently announced quarterly report
Recommended Actions
Find VP level buyers at Demiurge Technologies
Find 3 more new buyers
Company Profile Activity
Activity Insights
Demiurge Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Demiurge Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Demiurge Technologies.
Demiurge Technologies financials insights
Gather financial insights about Demiurge Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$7.7M
Demiurge Technologies Tech Stack
A closer look at the technologies used by Demiurge Technologies
Demiurge Technologies News & Media
Demiurge AI Discovers the Complete Aetiology of COVID-19 and the Optimal Treatment Strategy for COVID-19
Demiurge Technologies AG, a Swiss AI-biopharma company, announces the world's first discovery of the complete aetiology of COVID-19, as well as the optimal treatment strategy for COVID-19. (PRWeb March 09, 2020) Read the full story at https://www.prweb.com/releases/demiurge_ai_discovers_the_complete_aetiology_of_covid_19_and_the_optimal_treatment_strategy_for_covid_19/prweb16966447.htm
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Demiurge Technologies
Sign Up For FreeTo access detailed company insights
Demiurge Technologies specializes in bridging deep learning and life sciences to create virtual patients that can predict clinical trial outcomes for complex diseases. Their platform has achieved high accuracy rates in predicting the efficacy of drugs across various therapeutic areas, including COVID-19, Alzheimer's disease, and immuno-oncology. Th... Read More
